pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 19·1 min read
save

Federal grant delays threaten disability research and services

Jun 19, 2026·read at STAT ↗RegulatoryNegative

Grants from the National Institute on Disability, Independent Living, and Rehabilitation Research have been postponed by several months, leaving researchers uncertain about funding.

The delays are causing anxiety among disability scholars nationwide, who fear for their jobs and the continuity of programs that support people with disabilities.

Robert Gould, a professor at University of Illinois Chicago and director of the Great Lakes ADA Center, warned that the slowdown could undo decades of work that helps individuals navigate the Americans with Disabilities Act.

The Great Lakes ADA Center, part of a national network that offers services such as a hotline for disability‑related assistance, may see its operations curtailed if the funding gap persists.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Federal grant delays could jeopardize essential disability services, research”

read at STAT ↗
1,441 words · retrieved Jun 19
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.2HORIZONNational Institutes of Health
drugs
Rare Disease2Obesity
topics
Psychiatry & CNS3Rare Disease2ObesityVaccine

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jul 9Who’s going to run the FDA?STAT
  • Dec 23Fierce Biotech Layoff Tracker 2026: Caribou cuts staff, halts pipeline; Foghorn reduces workforce by 40%Fierce Biotech
  • Sep 25Federal judge rolls back landmark disability protectionsSTAT
  • Sep 23The latest in the legal saga for youth gender-affirming care in the U.S.STAT